Roche Holding AG (LON: 0QQ6)
London
· Delayed Price · Currency is GBP · Price in CHF
286.70
+3.10 (1.09%)
Jan 14, 2025, 9:04 AM BST
Roche Holding AG Revenue
Roche Holding AG had revenue of 30.76B CHF in the half year ending June 30, 2024, a decrease of -9.27%. This brings the company's revenue in the last twelve months to 60.58B, down -3.12% year-over-year. In the year 2023, Roche Holding AG had annual revenue of 60.44B, down -8.16%.
Revenue (ttm)
60.58B CHF
Revenue Growth
-3.12%
P/S Ratio
n/a
Revenue / Employee
584.73K CHF
Employees
103,605
Market Cap
190.56B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
Dec 31, 2019 | 63.75B | 4.25B | 7.15% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Roche Holding AG News
- 4 days ago - Roche Finalizes Poseida Acquisition: This Cell Therapy Deal Feels Like A Win/Win - Seeking Alpha
- 5 days ago - Roche's momentum in digital pathology continues with FDA clearance on its high-volume slide scanner - PRNewsWire
- 6 days ago - Roche to close $1.5B acquisition of Poseida Therapeutics - Seeking Alpha
- 6 days ago - Roche to complete acquisition of U.S. biopharma company Poseida - Reuters
- 6 days ago - Roche purchases shares in tender offer for Poseida Therapeutics, Inc. - GlobeNewsWire
- 6 days ago - Roche Vabysmo Sales Surpassed USD 4 Billion In 2024 - GlobeNewsWire
- 10 days ago - Roche Executing Commercially, But R&D Productivity Remains A Work In Progress - Seeking Alpha
- 11 days ago - Roche, Innovent ink licensing deal for lung cancer drug - Seeking Alpha